AU2001271718A1 - Fatty acid synthase inhibitors - Google Patents
Fatty acid synthase inhibitorsInfo
- Publication number
- AU2001271718A1 AU2001271718A1 AU2001271718A AU7171801A AU2001271718A1 AU 2001271718 A1 AU2001271718 A1 AU 2001271718A1 AU 2001271718 A AU2001271718 A AU 2001271718A AU 7171801 A AU7171801 A AU 7171801A AU 2001271718 A1 AU2001271718 A1 AU 2001271718A1
- Authority
- AU
- Australia
- Prior art keywords
- fatty acid
- acid synthase
- synthase inhibitors
- inhibitors
- fatty
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 102000015303 Fatty Acid Synthases Human genes 0.000 title 1
- 108010039731 Fatty Acid Synthases Proteins 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
- C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
- C07D317/44—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D317/46—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 ortho- or peri-condensed with carbocyclic rings or ring systems condensed with one six-membered ring
- C07D317/48—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring
- C07D317/62—Methylenedioxybenzenes or hydrogenated methylenedioxybenzenes, unsubstituted on the hetero ring with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to atoms of the carbocyclic ring
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US21488900P | 2000-06-29 | 2000-06-29 | |
| US60214889 | 2000-06-29 | ||
| PCT/US2001/020926 WO2002002119A1 (en) | 2000-06-29 | 2001-06-29 | Fatty acid synthase inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU2001271718A1 true AU2001271718A1 (en) | 2002-01-14 |
Family
ID=22800799
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2001271718A Abandoned AU2001271718A1 (en) | 2000-06-29 | 2001-06-29 | Fatty acid synthase inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU2001271718A1 (en) |
| WO (1) | WO2002002119A1 (en) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4711621B2 (en) | 2001-06-12 | 2011-06-29 | ウェルスタット セラピューティクス コーポレイション | Compounds for the treatment of metabolic disorders |
| EP1556085A4 (en) | 2002-11-01 | 2012-08-22 | Wellstat Therapeutics Corp | COMPOUNDS FOR THE TREATMENT OF METABOLISM |
| HUE045701T2 (en) | 2013-03-13 | 2020-01-28 | Forma Therapeutics Inc | 2-Hydroxy-1- {4 - [(4-phenylphenyl) carbonyl] piperazin-1-yl} ethan-1-one derivatives and related compounds as fatty acid synthase (FASN) inhibitors for the treatment of cancer |
| TWI767148B (en) | 2018-10-10 | 2022-06-11 | 美商弗瑪治療公司 | Inhibiting fatty acid synthase (fasn) |
| WO2020092395A1 (en) | 2018-10-29 | 2020-05-07 | Forma Therapeutics, Inc. | SOLID FORMS OF (4-(2-FLUORO-4-(1-METHYL-1 H-BENZO[d]IMIDAZOL-5-YL)BENZOYL) PIPERAZIN-1-YL)(1-HYDROXYCYCLOPROPYL)METHANONE |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO1992015558A1 (en) * | 1991-03-01 | 1992-09-17 | Zeria Pharmaceutical Co., Ltd. | Indian derivative and thromboxane antagonist containing the same |
-
2001
- 2001-06-29 AU AU2001271718A patent/AU2001271718A1/en not_active Abandoned
- 2001-06-29 WO PCT/US2001/020926 patent/WO2002002119A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO2002002119A1 (en) | 2002-01-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2001258771A1 (en) | -secretase inhibitors | |
| IL153230A0 (en) | Liposomal benzoquinazoline thymidylate synthase inhibitor formulations | |
| AU2001270200A1 (en) | Fatty acid synthase inhibitors | |
| AU2001278986A1 (en) | 3-amino-2-(4-aminocarbonyloxy)phenyl-propionic acid derivatives as alpha-4- integrin inhibitors | |
| AU2001281059A1 (en) | Fatty acid synthase inhibitors | |
| AU2001236052A1 (en) | Urease inhibitors | |
| AU2001280167A1 (en) | Novel propenohydroxamic acid derivatives | |
| AU2002222627A1 (en) | Tak1 inhibitors | |
| AU7961300A (en) | Kainic acid neurocytotoxicity inhibitors | |
| IL148324A0 (en) | Fatty acid synthase inhibitors | |
| AU2001271531A1 (en) | Fatty acid synthase inhibitors | |
| AU2003902413A0 (en) | Modification of fatty acid biosynthesis | |
| AU2002224550A1 (en) | Corrosion inhibitors | |
| GB0030284D0 (en) | Enzyme inhibitors | |
| AU2002243439A1 (en) | Fatty acid synthase inhibitors | |
| AU2001274940A1 (en) | Fatty acid synthase inhibitors | |
| IL151250A0 (en) | Difluorobutyric acid metalloprotease inhibitors | |
| AU6925500A (en) | Fatty acid synthase inhibitors | |
| AU2001271718A1 (en) | Fatty acid synthase inhibitors | |
| AU6926500A (en) | Fatty acid synthase inhibitors | |
| AU2001291160A1 (en) | Fatty acid synthase inhibitors | |
| AU2001284705A1 (en) | Fatty acid synthase inhibitors | |
| AUPQ851000A0 (en) | Rapid fatty acid delivery | |
| AU2001268853A1 (en) | Biocatalyst inhibitors | |
| AU2001269121A1 (en) | Substituted amidoalkyl-uracils as parp inhibitors |